<?xml version="1.0" encoding="UTF-8"?>
<p>However, to date, to the best of our knowledge, there are no systematic studies concerning neurotoxic manifestations of MQ, when used ad antiviral drug, and not for the antimalarial prophylaxis. It could be speculated that in some conditions the benefit:risk ratio would look more favorable than for MQ used for malaria chemoprophylaxis.</p>
